Experimental cell therapy targets dangerous virus in transplant patients
Disease control
Recruiting now
This study tests an experimental treatment for cytomegalovirus (CMV) infection in people who have had a stem cell transplant. The treatment uses special immune cells from the donor that are trained to attack CMV. The goal is to see if this approach is safe and can help clear the …
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated May 15, 2026 11:53 UTC